BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

19 articles for H Kagechika

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Development ofEBI
Tokyo Medical and Dental University
Development of 6-arylcoumarins as nonsteroidal progesterone antagonists. Structure-activity relationships and fluorescence properties.EBI
Ochanomizu University
Steric structure-activity relationship of cyproheptadine derivatives as inhibitors of histone methyltransferase Set7/9.EBI
Tokyo Medical and Dental University (Tmdu)
Identification of Cyproheptadine as an Inhibitor of SET Domain Containing Lysine Methyltransferase 7/9 (Set7/9) That Regulates Estrogen-Dependent Transcription.EBI
Riken
Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.EBI
Ochanomizu University
Development of 1,3-diphenyladamantane derivatives as nonsteroidal progesterone receptor antagonists.EBI
Tokyo Medical and Dental University
Design and Synthesis of 4-(4-Benzoylaminophenoxy)phenol Derivatives As Androgen Receptor Antagonists.EBI
Tokyo Medical and Dental University
6-arylcoumarins as novel nonsteroidal type progesterone antagonists: an example with receptor-binding-dependent fluorescence.EBI
Ochanomizu University
A potent and selective cis-amide inhibitor of ryanodine receptor 2 as a candidate for cardiac arrhythmia treatment.EBI
Tokyo Medical and Dental University (TMDU)
Lithocholic Acid Derivatives as Potent Vitamin D Receptor Agonists.EBI
Ochanomizu University
Structural development of N-(4-phenoxyphenyl)benzamide derivatives as novel SPAK inhibitors blocking WNK kinase signaling.EBI
Tokyo Medical and Dental University (Tmdu)
Development of novel lithocholic acid derivatives as vitamin D receptor agonists.EBI
Tokyo Medical and Dental University
Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers.EBI
University of Tokyo
Structure-activity relationship study on benzoic acid part of diphenylamine-based retinoids.EBI
Tohoku Pharmaceutical University
Structure-activity relationship of novel (benzoylaminophenoxy)phenol derivatives as anti-prostate cancer agents.EBI
Ochanomizu University
Novel Nonsteroidal Progesterone Receptor (PR) Antagonists with a Phenanthridinone Skeleton.EBI
The University of Tokyo
Development of WNK signaling inhibitors as a new class of antihypertensive drugs.EBI
Tokyo Medical and Dental University (Tmdu)
Development of nonsteroidal glucocorticoid receptor modulators based on N-benzyl-N-(4-phenoxyphenyl)benzenesulfonamide scaffold.EBI
The University of Tokyo